Description
Zotide ONE 600mcg Injection contains teriparatide, a recombinant form of parathyroid hormone used in the treatment of osteoporosis. It helps increase bone density and reduce the risk of fractures in patients with weakened bones.
This injectable therapy is commonly prescribed for postmenopausal women, men with osteoporosis, and patients at high risk of fractures due to long-term steroid use or other conditions affecting bone strength.
Uses
- Treatment of osteoporosis in postmenopausal women
- Osteoporosis in men at high risk of fractures
- Bone loss due to long-term corticosteroid use
Benefits
- Stimulates new bone formation
- Increases bone mineral density
- Reduces risk of fractures
- Effective in severe osteoporosis cases
How It Works
Teriparatide is an anabolic (bone-building) agent that stimulates osteoblast activity. Unlike other treatments that slow bone loss, it actively promotes the formation of new bone, improving bone strength and structure.
